Casper Tidemandsen

DFV890: a new oral NLRP3 inhibitor—tested in an early phase 2a randomised clinical trial in patients with COVID-19 pneumonia and impaired respiratory function

Ildikó Madurka, Alexander Vishnevsky, Joan B. Soriano et al. · Infection · 2022 · 83 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +10

Azithromycin and hydroxychloroquine in hospitalised patients with confirmed COVID-19: a randomised double-blinded placebo-controlled trial

Pradeesh Sivapalan, Charlotte Suppli Ulrik, Thérèse Lapperre et al. · European Respiratory Journal · 2021 · 48 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +16

Asthma Is Associated With Pregnancy Loss and Recurrent Pregnancy Loss: A Nationwide Cohort Study

Casper Tidemandsen, Pia Egerup, Charlotte Suppli Ulrik et al. · The Journal of Allergy and Clinical Immunology In Practice · 2022 · 11 citations

Medicine, Gynecology, Obstetrics +14